Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Pallone Outflanks Eshoo To Win Top Dem Spot On Energy And Commerce

This article was originally published in The Gray Sheet

Executive Summary

Rep. Frank Pallone will be ranking member of the House Energy and Commerce Committee in January, beating out House Medical Technology Caucus Co-Chair Rep. Anna Eshoo for the spot. Health care is expected to be an active legislative focus for Energy and Commerce next year.

You may also be interested in...



FDA Will Face Reforms, Oversight In Republican Congress, Analysts Say

Election gains by Republicans will embolden Congress to put FDA in its oversight “crosshairs,” as members of key Senate and House panels scrutinize how the agency is using its resources. Reforms could also come soon as part of the ongoing 21st Century Cures initiative.

Congress, FDA Commissioner Question Device Pre-Market Review Process

House Energy and Commerce Health Subcommittee Chair Frank Pallone said legislation is needed to restrict the types of devices cleared through FDA's 510(k) process

Draft Bill Would Overrule Supreme Court’s Device Pre-emption Support

House Democrats plan to introduce a bill next month to reverse the impact of the recent Riegel v. Medtronic U.S. Supreme Court decision protecting PMA-approved devices in most cases from personal injury lawsuits

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT033505

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel